
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials
Ryuhei Okada, Aki Furusawa, Daniel W. Vermeer, et al.
EBioMedicine (2021) Vol. 67, pp. 103345-103345
Open Access | Times Cited: 31
Ryuhei Okada, Aki Furusawa, Daniel W. Vermeer, et al.
EBioMedicine (2021) Vol. 67, pp. 103345-103345
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy
T. M. Mohiuddin, Chaoyu Zhang, Wenjie Sheng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2655-2655
Open Access | Times Cited: 32
T. M. Mohiuddin, Chaoyu Zhang, Wenjie Sheng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2655-2655
Open Access | Times Cited: 32
Near-infrared organic light-emitting materials, devices and applications
Mengxin Xu, Xinyi Li, Shihao Liu, et al.
Materials Chemistry Frontiers (2023) Vol. 7, Iss. 20, pp. 4744-4767
Closed Access | Times Cited: 23
Mengxin Xu, Xinyi Li, Shihao Liu, et al.
Materials Chemistry Frontiers (2023) Vol. 7, Iss. 20, pp. 4744-4767
Closed Access | Times Cited: 23
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer
Hiroshi Fukushima, Seiichiro Takao, Aki Furusawa, et al.
Cancer Letters (2024) Vol. 585, pp. 216606-216606
Closed Access | Times Cited: 8
Hiroshi Fukushima, Seiichiro Takao, Aki Furusawa, et al.
Cancer Letters (2024) Vol. 585, pp. 216606-216606
Closed Access | Times Cited: 8
Near infrared photoimmunotherapy for cancers: A translational perspective
Yasuhiro Maruoka, Hiroaki Wakiyama, Peter L. Choyke, et al.
EBioMedicine (2021) Vol. 70, pp. 103501-103501
Open Access | Times Cited: 45
Yasuhiro Maruoka, Hiroaki Wakiyama, Peter L. Choyke, et al.
EBioMedicine (2021) Vol. 70, pp. 103501-103501
Open Access | Times Cited: 45
Recent strides in macromolecular targeted photodynamic therapy for cancer
Maxwell Quaye, Girgis Obaid
Current Opinion in Chemical Biology (2024) Vol. 81, pp. 102497-102497
Open Access | Times Cited: 6
Maxwell Quaye, Girgis Obaid
Current Opinion in Chemical Biology (2024) Vol. 81, pp. 102497-102497
Open Access | Times Cited: 6
Phototruncation cell tracking with near-infrared photoimmunotherapy using heptamethine cyanine dye to visualise migratory dynamics of immune cells
Hiroshi Fukushima, Aki Furusawa, Seiichiro Takao, et al.
EBioMedicine (2024) Vol. 102, pp. 105050-105050
Open Access | Times Cited: 5
Hiroshi Fukushima, Aki Furusawa, Seiichiro Takao, et al.
EBioMedicine (2024) Vol. 102, pp. 105050-105050
Open Access | Times Cited: 5
Near-infrared Photoimmunotherapy: mechanisms, applications, and future perspectives in cancer research
Donald O. Allen, Madeline JoAnna Szoo, Tessa D. van Bergen, et al.
Antibody Therapeutics (2025) Vol. 8, Iss. 1, pp. 68-85
Open Access
Donald O. Allen, Madeline JoAnna Szoo, Tessa D. van Bergen, et al.
Antibody Therapeutics (2025) Vol. 8, Iss. 1, pp. 68-85
Open Access
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody
Teruki Kobayashi, Kazuhiro Noma, Seitaro Nishimura, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 7, pp. 1031-1042
Closed Access | Times Cited: 4
Teruki Kobayashi, Kazuhiro Noma, Seitaro Nishimura, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 7, pp. 1031-1042
Closed Access | Times Cited: 4
Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models
Takuya Kato, Ryuhei Okada, Aki Furusawa, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 11, pp. 2262-2273
Open Access | Times Cited: 26
Takuya Kato, Ryuhei Okada, Aki Furusawa, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 11, pp. 2262-2273
Open Access | Times Cited: 26
Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, et al.
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3180-3192
Open Access | Times Cited: 16
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, et al.
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3180-3192
Open Access | Times Cited: 16
Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy
Takuya Kato, Ryuhei Okada, Yuto Goto, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 5, pp. 1689-1701
Open Access | Times Cited: 22
Takuya Kato, Ryuhei Okada, Yuto Goto, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 5, pp. 1689-1701
Open Access | Times Cited: 22
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
Hiroshi Fukushima, Barış Türkbey, Peter A. Pinto, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2996-2996
Open Access | Times Cited: 15
Hiroshi Fukushima, Barış Türkbey, Peter A. Pinto, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2996-2996
Open Access | Times Cited: 15
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy
Ryuhei Okada, Takuya Kato, Aki Furusawa, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 8, pp. 1877-1887
Open Access | Times Cited: 14
Ryuhei Okada, Takuya Kato, Aki Furusawa, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 8, pp. 1877-1887
Open Access | Times Cited: 14
Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model
Michelle A. Hsu, Stephanie M. Okamura, C. Daniel De Magalhaes Filho, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 1, pp. 151-168
Open Access | Times Cited: 14
Michelle A. Hsu, Stephanie M. Okamura, C. Daniel De Magalhaes Filho, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 1, pp. 151-168
Open Access | Times Cited: 14
Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model
Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, et al.
Cancer Science (2021) Vol. 112, Iss. 8, pp. 3041-3049
Open Access | Times Cited: 18
Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, et al.
Cancer Science (2021) Vol. 112, Iss. 8, pp. 3041-3049
Open Access | Times Cited: 18
Utilization of ultrasound in photoimmunotherapy for head and neck cancer: a case report
Toshihiro Kishikawa, Hoshino Terada, Michi Sawabe, et al.
Journal of Ultrasound (2023)
Closed Access | Times Cited: 7
Toshihiro Kishikawa, Hoshino Terada, Michi Sawabe, et al.
Journal of Ultrasound (2023)
Closed Access | Times Cited: 7
Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
Hiroshi Fukushima, Aki Furusawa, Seiichiro Takao, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Hiroshi Fukushima, Aki Furusawa, Seiichiro Takao, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Photoimmunotherapy: A New Paradigm in Solid Tumor Immunotherapy
Zheng Peng, Xiaolan Lv, Shigao Huang
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 12
Zheng Peng, Xiaolan Lv, Shigao Huang
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 12
Translational research in head and neck cancer: Molecular and immunological updates
Takumi Kumai, Hirotaka Shinomiya, Hirofumi Shibata, et al.
Auris Nasus Larynx (2023) Vol. 51, Iss. 2, pp. 391-400
Closed Access | Times Cited: 6
Takumi Kumai, Hirotaka Shinomiya, Hirofumi Shibata, et al.
Auris Nasus Larynx (2023) Vol. 51, Iss. 2, pp. 391-400
Closed Access | Times Cited: 6
Trastuzumab‐based near‐infrared photoimmunotherapy in xenograft mouse of breast cancer
Susumu Yamashita, Miho Kojima, Nobuhiko Onda, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4579-4589
Open Access | Times Cited: 9
Susumu Yamashita, Miho Kojima, Nobuhiko Onda, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4579-4589
Open Access | Times Cited: 9
Near-infrared photoimmunotherapy and anti-cancer immunity
Kohei Nakajima, Mikako Ogawa
International Immunology (2023) Vol. 36, Iss. 2, pp. 57-64
Open Access | Times Cited: 5
Kohei Nakajima, Mikako Ogawa
International Immunology (2023) Vol. 36, Iss. 2, pp. 57-64
Open Access | Times Cited: 5
Antitumor host immunity enhanced by near‐infrared photoimmunotherapy
Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, et al.
Cancer Science (2024)
Open Access | Times Cited: 1
Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, et al.
Cancer Science (2024)
Open Access | Times Cited: 1
Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy
Hideyuki Furumoto, Ryuhei Okada, Takuya Kato, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4042-4042
Open Access | Times Cited: 6
Hideyuki Furumoto, Ryuhei Okada, Takuya Kato, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4042-4042
Open Access | Times Cited: 6
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts
Hideyuki Furumoto, Takuya Kato, Hiroaki Wakiyama, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 846-846
Open Access | Times Cited: 5
Hideyuki Furumoto, Takuya Kato, Hiroaki Wakiyama, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 846-846
Open Access | Times Cited: 5
Near-infrared photoimmunotherapy for osteosarcoma targeting epidermal growth factor receptor
Motofumi Suzuki, Hisataka Kobayashi, Hirofumi Hanaoka
Translational Oncology (2024) Vol. 50, pp. 102132-102132
Open Access
Motofumi Suzuki, Hisataka Kobayashi, Hirofumi Hanaoka
Translational Oncology (2024) Vol. 50, pp. 102132-102132
Open Access